Skip to content

ESWT for Shoulder Pain in Patients With Brain Damage

The Effects of Extracorporeal Shockwave Therapy (ESWT) for Shoulder Pain in Patients With Brain Damage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04320108
Enrollment
6
Registered
2020-03-24
Start date
2020-05-29
Completion date
2023-12-11
Last updated
2025-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Damage, Hypoxic, Brain Tumor, ICH, Stroke

Keywords

Extracorporeal shockwave therapy, Brain damage, Pain

Brief summary

This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.

Detailed description

6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/mm\^2, tolerable range) on subscapularis and lesser and greater tuberlces of humerus to reduce pain in patients with brain damage

Interventions

DEVICEExtracorporeal shockwave therapy

Extracorporeal shockwave therapy 6 times during 2 weeks

Sponsors

Bundang CHA Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Brain damaged patient confirmed in the brain image * 1 month after brain damage * Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS) * Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE) * Age: 20 and older * Person who has agreed in writing to decide his or her participation and comply with the precautions

Exclusion criteria

* Pain due to trauma * Injection treatments two weeks before participating in the study * Severe coagulopathy (excluding antiplatelet use) * Impaired cognition

Design outcomes

Primary

MeasureTime frameDescription
Numerical rating scale (NRS)Up to 4 weeks (baseline, after each treatment during 2 weeks, 2 weeks + 1 day, 4 weeks)Pain intensity (0-10, ordinal scale)

Secondary

MeasureTime frameDescription
Shoulder Pain and Disability Index (SPADI)Up to 4 weeks (baseline, 2 weeks + 1 day, 4 weeks)Scoring scale consist of 5 pain scale and 8 disability scale, in %, 0 (best) to 100 (worst)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026